These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18078271)

  • 1. Chemotherapy for brain metastases: breast, gynecologic and non-melanoma skin malignancies.
    Shah GD; Abrey LE
    Cancer Treat Res; 2007; 136():185-97. PubMed ID: 18078271
    [No Abstract]   [Full Text] [Related]  

  • 2. The Blood Brain Barrier and BRAF inhibitors: Implications for patients with melanoma brain metastases.
    Smalley KSM; Forsyth PA
    Pharmacol Res; 2018 Sep; 135():265-267. PubMed ID: 29146209
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of brain metastases in uncommon tumors.
    Tosoni A; Lumachi F; Brandes AA
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):783-93. PubMed ID: 15485313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant treatment of a solitary melanoma brain metastasis with vemurafenib.
    Kolar GR; Miller-Thomas MM; Schmidt RE; Simpson JR; Rich KM; Linette GP
    J Clin Oncol; 2013 Jan; 31(3):e40-3. PubMed ID: 23233711
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of brain metastases from melanoma.
    McWilliams RR; Brown PD; Buckner JC; Link MJ; Markovic SN
    Mayo Clin Proc; 2003 Dec; 78(12):1529-36. PubMed ID: 14661682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma. A prospective study.
    Nieder C
    Cancer; 1999 Sep; 86(5):900-3. PubMed ID: 10463993
    [No Abstract]   [Full Text] [Related]  

  • 7. Systemic Therapies for Melanoma Brain Metastases: A Primer for Radiologists.
    Dodson C; Smith DA; Richards TJ; Devita RR; Hoimes CJ; Ramaiya NH
    J Comput Assist Tomogr; 2020; 44(3):346-355. PubMed ID: 32217896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic treatments for brain metastases from breast cancer, non-small cell lung cancer, melanoma and renal cell carcinoma: an overview of the literature.
    Lombardi G; Di Stefano AL; Farina P; Zagonel V; Tabouret E
    Cancer Treat Rev; 2014 Sep; 40(8):951-9. PubMed ID: 24909312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete regression of a previously untreated melanoma brain metastasis with ipilimumab.
    Schartz NE; Farges C; Madelaine I; Bruzzoni H; Calvo F; Hoos A; Lebbé C
    Melanoma Res; 2010 Jun; 20(3):247-50. PubMed ID: 20216240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma.
    Schouten LJ; Rutten J; Huveneers HA; Twijnstra A
    Cancer; 2002 May; 94(10):2698-705. PubMed ID: 12173339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgical treatment of non-colorectal and non-endocrine liver metastases].
    Malassagne B; Goere D; Cherqui D; Fagniez PL
    Gastroenterol Clin Biol; 2000 Dec; 24(12):1177-85. PubMed ID: 11173730
    [No Abstract]   [Full Text] [Related]  

  • 12. Absent response of intracranial melanoma metastases harboring BRAF V600E sequence variation to vemurafenib.
    D'Alonzo D; Glatz K
    Mayo Clin Proc; 2013 Dec; 88(12):e151-2. PubMed ID: 24290130
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and clinical activity of ipilimumab in melanoma patients with brain metastases: retrospective analysis of data from a phase 2 trial.
    Weber JS; Amin A; Minor D; Siegel J; Berman D; O'Day SJ
    Melanoma Res; 2011 Dec; 21(6):530-4. PubMed ID: 22051508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgical and conservative treatment of metastases to the brain].
    Bolewski J
    Neurol Neurochir Pol; 1992; 26(1):73-81. PubMed ID: 1528368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.
    Goldberg SB; Gettinger SN; Mahajan A; Chiang AC; Herbst RS; Sznol M; Tsiouris AJ; Cohen J; Vortmeyer A; Jilaveanu L; Yu J; Hegde U; Speaker S; Madura M; Ralabate A; Rivera A; Rowen E; Gerrish H; Yao X; Chiang V; Kluger HM
    Lancet Oncol; 2016 Jul; 17(7):976-983. PubMed ID: 27267608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating metastatic melanoma: further considerations.
    Legha SS
    Oncology (Williston Park); 2009 May; 23(6):500, 508. PubMed ID: 19544691
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term survival of a patient with metastatic melanoma treated with nivolumab and vemurafenib, with the development of vitiligo.
    Fukumoto T; Fujiwara S; Sakaguchi M; Oka M; Kiyota N; Ejima Y; Nakajima K; Nishigori C
    Eur J Dermatol; 2017 Apr; 27(2):177-178. PubMed ID: 27873735
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapid regression of metastatic brain tumours in a melanoma patient after dabrafenib/trametinib therapy.
    Komori T; Otsuka A; Kusuba N; Taniguchi K; Endo Y; Honda T; Kabashima K
    Eur J Dermatol; 2017 Oct; 27(5):548-549. PubMed ID: 29084644
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune checkpoint blockade in patients with melanoma metastatic to the brain.
    Di Giacomo AM; Margolin K
    Semin Oncol; 2015 Jun; 42(3):459-65. PubMed ID: 25965364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastasis to the breast.
    Paulus DD; Libshitz HI
    Radiol Clin North Am; 1982 Sep; 20(3):561-8. PubMed ID: 7111707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.